These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33067069)

  • 21. Improving HPV vaccination rates among young males in rural areas of the United States.
    Vogel NP; Appel SJ; Winker G
    Nurse Pract; 2018 Jan; 43(1):1-6. PubMed ID: 29240623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic HPV vaccination for the prevention of cervical cancer.
    Hernandez BY
    Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
    [No Abstract]   [Full Text] [Related]  

  • 23. Policy opportunities to increase HPV vaccination in rural communities.
    Vanderpool RC; Stradtman LR; Brandt HM
    Hum Vaccin Immunother; 2019; 15(7-8):1527-1532. PubMed ID: 30608894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus (HPV) and influenza vaccine behavior among Muslim women in the United States.
    Hearld KR; Budhwani H
    Health Care Women Int; 2020 May; 41(5):532-542. PubMed ID: 31194672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan.
    Baussano I; Sayinzoga F; Tshomo U; Tenet V; Vorsters A; Heideman DAM; Gheit T; Tommasino M; Umulisa MC; Franceschi S; Clifford GM
    Emerg Infect Dis; 2021 Jan; 27(1):1-9. PubMed ID: 33350922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus vaccination in lgbtq patients: the need for dermatologists on the front lines.
    Cartron AM; Trinidad JC
    Cutis; 2020 Oct; 106(4):159-161. PubMed ID: 33186424
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe.
    Soldan K; Dillner J
    Euro Surveill; 2006 Nov; 11(11):E061123.3. PubMed ID: 17213557
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 Vaccination in Children: Lessons Learned From Human Papillomavirus Vaccination.
    Mansfield LN; Balasuriya L; Brown A
    J Adolesc Health; 2022 Apr; 70(4):525-527. PubMed ID: 35172932
    [No Abstract]   [Full Text] [Related]  

  • 30. Differences in Human Papillomavirus Vaccination Among Adolescent Girls in Metropolitan Versus Non-metropolitan Areas: Considering the Moderating Roles of Maternal Socioeconomic Status and Health Care Access.
    Monnat SM; Rhubart DC; Wallington SF
    Matern Child Health J; 2016 Feb; 20(2):315-25. PubMed ID: 26511129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mandating HPV vaccination: what are the arguments?
    Smith CM
    J Christ Nurs; 2008; 25(2):74-80; quiz 81-2. PubMed ID: 18401926
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines.
    Constable C; Caplan A
    Vaccine; 2020 Jan; 38(5):954-962. PubMed ID: 31843271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human papillomavirus vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].
    Abarca V K; Valenzuela B MT; Vergara F R; Luchsinger F V; Muñoz M A; Jiménez de la Jara J; Ripoll M E; O'Ryan G M
    Rev Chilena Infectol; 2008 Dec; 25(6):428-34. PubMed ID: 19194605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rural-urban differences in human papillomavirus knowledge and awareness among US adults.
    Mohammed KA; Subramaniam DS; Geneus CJ; Henderson ER; Dean CA; Subramaniam DP; Burroughs TE
    Prev Med; 2018 Apr; 109():39-43. PubMed ID: 29378268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
    Arana JE; Harrington T; Cano M; Lewis P; Mba-Jonas A; Rongxia L; Stewart B; Markowitz LE; Shimabukuro TT
    Vaccine; 2018 Mar; 36(13):1781-1788. PubMed ID: 29477308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women.
    Sonawane K; Nyitray AG; Nemutlu GS; Swartz MD; Chhatwal J; Deshmukh AA
    JAMA Netw Open; 2019 Dec; 2(12):e1918571. PubMed ID: 31880792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV vaccine: a cornerstone of female health.
    Temte JL
    Am Fam Physician; 2007 Jan; 75(1):28, 30. PubMed ID: 17225700
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccination Against Human Papillomavirus.
    Marks DH; Katz KA
    JAMA Dermatol; 2020 Nov; 156(11):1246-1247. PubMed ID: 32822454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urban-Rural Inequities in the Parental Attitudes and Beliefs Towards Human Papillomavirus Infection, Cervical Cancer, and Human Papillomavirus Vaccine in Mysore, India.
    Degarege A; Krupp K; Fennie K; Li T; Stephens DP; Marlow LAV; Srinivas V; Arun A; Madhivanan P
    J Pediatr Adolesc Gynecol; 2018 Oct; 31(5):494-502. PubMed ID: 29596907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus vaccination: a missed opportunity.
    Pender E; Griffin L
    Br J Dermatol; 2022 Oct; 187(4):584-585. PubMed ID: 35665487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.